{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:50:58Z","timestamp":1789019458558,"version":"build-2803163510"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13311-023-01413-0","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:02:21Z","timestamp":1692273741000},"page":"1496-1507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury"],"prefix":"10.1016","volume":"20","author":[{"given":"Daniel T.","family":"Laskowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-2803","authenticated-orcid":false,"given":"David W.","family":"Van Wyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management","volume":"104","author":"Capizzi","year":"2020","journal-title":"Med Clin North Am."},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib2","first-page":"1","article-title":"Estimating the global incidence of traumatic brain injury","volume":"2018","author":"Dewan","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01413-0_bib3","series-title":"Epidemiology of TBI in: traumatic brain injury rehabilitation medicine","first-page":"6","author":"Janak","year":"2015"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib4","first-page":"803","article-title":"Factors contributing to outcome following traumatic brain injury","volume":"32","author":"Ponsford","year":"2013","journal-title":"Neuro Rehabilitation"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csm.2020.08.013","article-title":"Epidemiology of sports-related concussion","volume":"40","author":"Pierpoint","year":"2021","journal-title":"Clin Sports Med."},{"key":"10.1007\/s13311-023-01413-0_bib6","unstructured":"Centers for Disease Control and Prevention. National center for health statistics: mortality data on CDC WONDER. Available at: https:\/\/wonder.cdc.gov. Accessed December 16, 2022."},{"issue":"17\u201318","key":"10.1007\/s13311-023-01413-0_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/neu.2022.0103","article-title":"Military traumatic brain injury: the history, impact and future","volume":"39","author":"Lindberg","year":"2022","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3389\/fneur.2020.00753","article-title":"Pulsed microwave energy transduction of acoustic phonon related brain injury","volume":"11","author":"Hubler","year":"2020","journal-title":"Front Neurol"},{"issue":"19","key":"10.1007\/s13311-023-01413-0_bib9","first-page":"396","article-title":"Havana syndrome might be the result of energy pulses","volume":"2021","author":"Nelson","year":"2021","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01413-0_bib10","unstructured":"DoD worldwide numbers for TBI. In: TBI center of excellence [online]. 10 August 2022. Available at: https:\/\/health.mil\/Military-Health-Topics\/Centers-of-Excellence\/Traumatic-Brain-Injury-Center-of-Excellence\/DOD-TBI-Worldwide-Numbers. Accessed November 3, 2022."},{"issue":"3","key":"10.1007\/s13311-023-01413-0_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/HTR.0000000000000156","article-title":"Trends in sports- and recreation-related traumatic brain injuries treated in US emergency departments: the National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) 2001\u20132012","volume":"30","author":"Coronado","year":"2015","journal-title":"J Head Trauma Rehabil"},{"issue":"10","key":"10.1007\/s13311-023-01413-0_bib12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1080\/09602011.2020.1787849","article-title":"Surviving the \u201csilent epidemic\u201d: a qualitative exploration of the long-term journey after traumatic brain injury","volume":"31","author":"Lefkovits","year":"2021","journal-title":"Neuropsych Rehabil"},{"issue":"10","key":"10.1007\/s13311-023-01413-0_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1474-4422(17)30279-X","article-title":"The chronic and evolving neurological consequences of traumatic brain injury","volume":"16","author":"Wilson","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-023-01413-0_bib14","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s00415-019-09541-4","article-title":"Recent advances in traumatic brain injury","volume":"266","author":"Khellaf","year":"2019","journal-title":"J Neurol."},{"key":"10.1007\/s13311-023-01413-0_bib15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1089\/neu.2018.5778","article-title":"Pre-clinical testing of therapies for traumatic brain injury","volume":"35","author":"DeWitt","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib16","series-title":"An introduction to neuropathology","author":"Adams","year":"1994"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib17","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1038\/s41598-017-11947-x","article-title":"A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine\/D-serine","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01413-0_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-444-63954-7.00006-9","article-title":"Concussion: pathophysiology and clinical translation","volume":"158","author":"Giza","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib19","series-title":"Neurotrauma and critical care of the brain.","article-title":"Pathophysiology of traumatic brain injury","year":"2018"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1176\/jnp.2006.18.2.141","article-title":"Blast-related traumatic brain injury: what is known?","volume":"18","author":"Taber","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"13\u201314","key":"10.1007\/s13311-023-01413-0_bib21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3109\/02699052.2012.722257","article-title":"Randomized controlled trials in adult traumatic brain injury","volume":"16","author":"Lu","year":"2012","journal-title":"Brain Inj"},{"issue":"11","key":"10.1007\/s13311-023-01413-0_bib22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.apmr.2016.05.005","article-title":"Variations in inpatient rehabilitation functional outcomes across centers in the traumatic brain injury model systems study and the influence of demographics and injury severity on patient outcomes","volume":"97","author":"Dahdah","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"issue":"23","key":"10.1007\/s13311-023-01413-0_bib23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1089\/neu.2014.3352","article-title":"Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes","volume":"32","author":"Bramlett","year":"2015","journal-title":"J Neurotrauma"},{"issue":"19","key":"10.1007\/s13311-023-01413-0_bib24","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1089\/neu.2016.4767","article-title":"Head impact density: a model to explain the elusive concussion threshold","volume":"34","author":"Broglio","year":"2017","journal-title":"J Neurotrauma"},{"issue":"11","key":"10.1007\/s13311-023-01413-0_bib25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/02699050903200555","article-title":"The heterogeneity of mild traumatic brain injury: where do we stand?","volume":"23","author":"Tellier","year":"2009","journal-title":"Brain Inj"},{"issue":"8","key":"10.1007\/s13311-023-01413-0_bib26","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1089\/neu.2016.4618","article-title":"Mild traumatic brain injury: longitudinal study of cognition, functional status, and post-traumatic symptoms","volume":"34","author":"Dikmen","year":"2017","journal-title":"J Neurotrauma"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1476-5381.2010.01163.x","article-title":"Animal modeling of traumatic brain injury in preclinical drug development: where do we go from here","volume":"164","author":"Marklund","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-023-01413-0_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.10098","article-title":"Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema","volume":"51","author":"Lynch","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002331","article-title":"Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke","volume":"14","author":"Holman","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1007\/s13311-023-01413-0_bib31","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1073\/pnas.1618569114","article-title":"Meta-assessment of bias in science","volume":"114","author":"Fanelli","year":"2016","journal-title":"PNAS"},{"issue":"11","key":"10.1007\/s13311-023-01413-0_bib32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3109\/02699052.2015.1065344","article-title":"Embracing failure: what the phase III progesterone studies can teach about TBI clinical trials","volume":"29","author":"Stein","year":"2015","journal-title":"Brain Inj"},{"issue":"13","key":"10.1007\/s13311-023-01413-0_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/138161206776843340","article-title":"Evaluation of pharmacological treatment strategies in traumatic brain injury","volume":"12","author":"Marklund","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1007\/s13311-023-01413-0_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneumeth.2018.10.027","article-title":"Variability and uncertainty in the rodent controlled cortical impact model of traumatic brain injury","volume":"312","author":"Sellappan","year":"2019","journal-title":"J Neurosci Methods"},{"key":"10.1007\/s13311-023-01413-0_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12975-014-0327-0","article-title":"Traumatic brain injury using mouse models","volume":"5","author":"Zhang","year":"2014","journal-title":"Transl Stroke Res"},{"issue":"6","key":"10.1007\/s13311-023-01413-0_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/089771501750291864","article-title":"Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse","volume":"18","author":"Pineda","year":"2001","journal-title":"J Neurotrauma"},{"issue":"3","key":"10.1007\/s13311-023-01413-0_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-0270(91)90104-8","article-title":"A controlled cortical impact model of traumatic brain injury in the rat","volume":"39","author":"Dixon","year":"1991","journal-title":"J NeuroSci Methods"},{"key":"10.1007\/s13311-023-01413-0_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e813","article-title":"Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study","volume":"344","author":"Bafeta","year":"2012","journal-title":"BMJ"},{"key":"10.1007\/s13311-023-01413-0_bib39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1089\/neu.2015.4233","article-title":"A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury","volume":"33","author":"Bragge","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(13)70234-5","article-title":"Advancing care for traumatic for traumatic brain injury: findings from the IMPACT studies and perspectives on future research","volume":"12","author":"Maas","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2012.00003","article-title":"Bench-to-bedside and bedside back to bench; coordinating clinical and experimental traumatic brain injury studies","volume":"3","author":"Agoston","year":"2012","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/neu.2007.0510","article-title":"Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials","volume":"25","author":"Lu","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/neu.2017.5583","article-title":"Genetic influences on patient-oriented outcomes in traumatic brain injury: a living systematic review of non-apolipoprotein e single-nucleotide polymorphisms","volume":"38","author":"Zeiler","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure-function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv Protein Chem"},{"key":"10.1007\/s13311-023-01413-0_bib45","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/pro.2379","article-title":"Concerning the structure of apoE","volume":"22","author":"Frieden","year":"2013","journal-title":"Protein Sci"},{"key":"10.1007\/s13311-023-01413-0_bib46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"89","key":"10.1007\/s13311-023-01413-0_bib47","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med."},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/exnr.1996.0064","article-title":"Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins","volume":"138","author":"Fleming","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/neu.2007.0489","article-title":"Meta-analysis of APOE4 allele and outcome after traumatic brain injury","volume":"25","author":"Zhou","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/gtmb.2013.0421","article-title":"Prognostic value of apolipoprotein E epsilon4 allele in patients with traumatic brain injury: a meta-analysis and meta-regression","volume":"18","author":"Zeng","year":"2014","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10.1007\/s13311-023-01413-0_bib51","first-page":"78","article-title":"Apolipoprotein E epsilon 4 genotype, mild traumatic brain injury, and the development of chronic traumatic encephalopathy","volume":"6","author":"Deng","year":"2018","journal-title":"Med Sci"},{"key":"10.1007\/s13311-023-01413-0_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamaneurol.2022.1634","article-title":"Association of apoE genotypes and chronic traumatic encephalopathy","volume":"79","author":"Atherton","year":"2022","journal-title":"JAMA Neurol"},{"issue":"02","key":"10.1007\/s13311-023-01413-0_bib53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.1997.03550020068040","article-title":"Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing","volume":"278","author":"Jordan","year":"1997","journal-title":"JAMA"},{"issue":"03","key":"10.1007\/s13311-023-01413-0_bib54","first-page":"651","article-title":"Lower cognitive performance of older football players possessing apolipoprotein E epsilon 4","volume":"47","author":"Kutner","year":"2000","journal-title":"Neurosurgery"},{"issue":"13","key":"10.1007\/s13311-023-01413-0_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.0b013e3182a55f7f","article-title":"Clinical presentation of chronic traumatic encephalopathy","volume":"81","author":"Stern","year":"2013","journal-title":"Neurology"},{"issue":"Pt 1","key":"10.1007\/s13311-023-01413-0_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"issue":"6","key":"10.1007\/s13311-023-01413-0_bib57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-015-1502-4","article-title":"Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank","volume":"130","author":"Bieniek","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"10.1007\/s13311-023-01413-0_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-5728(97)00021-0","article-title":"Apolipoprotein E suppresses glial secretion of TNF alpha","volume":"76","author":"Laskowitz","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"6645","key":"10.1007\/s13311-023-01413-0_bib59","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01413-0_bib60","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin Imunol"},{"key":"10.1007\/s13311-023-01413-0_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cimb43010018","article-title":"Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells in vitro","author":"Iannucci","year":"2021","journal-title":"Curr Issues Mol Biol."},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/exnr.2001.7541","article-title":"Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptide","volume":"167","author":"Laskowitz","year":"2001","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1007\/s13311-023-01413-0_bib63","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/01.CCM.0000186368.96146.FB","article-title":"APOE polymorphism is associated with risk of severe sepsis in surgical patient","volume":"33","author":"Moretti","year":"2005","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1007\/s13311-023-01413-0_bib64","doi-asserted-by":"crossref","first-page":"e1243","DOI":"10.1212\/WNL.0000000000012512","article-title":"Impact of C-reactive protein on cognition and Alzheimer disease biomarkers in homozygous apolipoprotein E \u025b4 carriers","volume":"97","author":"Tao","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-018-0249-5","article-title":"Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury","volume":"13","author":"McCann","year":"2018","journal-title":"Mol Neurodegener"},{"issue":"6238","key":"10.1007\/s13311-023-01413-0_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/341162a0","article-title":"The ldl-receptor-related protein, lrp, is an apolipoprotein e-binding protein","volume":"341","author":"Beisiegel","year":"1989","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01413-0_bib67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.70.4.677","article-title":"Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages","volume":"70","author":"Misra","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"23","key":"10.1007\/s13311-023-01413-0_bib69","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1021\/bi036208p","article-title":"Two apolipoprotein E mimetic peptides, ApoE(130\u2013149) and ApoE(141\u2013155)2, bind to LRP1","volume":"43","author":"Croy","year":"2004","journal-title":"Biochemistry"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib70","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jmb.2010.03.022","article-title":"Structure of the minimal interface between ApoE and LRP","volume":"398","author":"Guttman","year":"2010","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12974-016-0772-7","article-title":"LRP1 modulates the microglial immune response via regulation of JNK and NF-\u03baB signaling pathways","volume":"13","author":"Yang","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"10.1007\/s13311-023-01413-0_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2009.06.010","article-title":"Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation","volume":"214","author":"Pocivavsek","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-023-01413-0_bib73","unstructured":"Yu AW, Cutcliffe HC, Laskowitz DT, et al. Neuroprotective effect of an ApoE mimetic peptide in a gyrencephalic blast animal model. Presented at the 2018 Military Health System Research Symposium; August 29\u201323, 2018. Orlando."},{"key":"10.1007\/s13311-023-01413-0_bib74","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1007\/s13311-023-01413-0_bib75","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0022-2275(20)32160-X","article-title":"Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo","volume":"39","author":"Roselaar","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1007\/s13311-023-01413-0_bib76","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)32147-7","article-title":"Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumonia infection","volume":"40","author":"de Bont","year":"1999","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib77","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","article-title":"Altered immune responses in apolipoprotein E-deficient mice","volume":"41","author":"Laskowitz","year":"2000","journal-title":"J Lipid Res"},{"issue":"1\u20132","key":"10.1007\/s13311-023-01413-0_bib78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(00)00459-8","article-title":"Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response","volume":"114","author":"Lynch","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1007\/s13311-023-01413-0_bib79","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.1074\/jbc.M009915200","article-title":"Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality: a new therapeutic approach to treat gram-negative sepsis","volume":"276","author":"Van Oosten","year":"2001","journal-title":"J Biol Chem"},{"issue":"49","key":"10.1007\/s13311-023-01413-0_bib80","doi-asserted-by":"crossref","first-page":"48529","DOI":"10.1074\/jbc.M306923200","article-title":"APOE genotype and an apoE-mimetic peptide modify the systemic and central nervous system inflammatory response","volume":"278","author":"Lynch","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib81","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1038\/s41598-020-76849-x","article-title":"APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with bryostatin-1 improves outcomes","volume":"10","author":"Giarratana","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/NCC:4:1:025","article-title":"A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage","volume":"4","author":"Gao","year":"2006","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib83","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/STROKEAHA.108.530402","article-title":"Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage","volume":"40","author":"James","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004647-199804000-00003","article-title":"Apolipoprotein E isoform specific differences in outcome from focal ischemia in transgenic mice","volume":"18","author":"Sheng","year":"1998","journal-title":"J Cereb Blood Flow and Metab"},{"issue":"5","key":"10.1007\/s13311-023-01413-0_bib85","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.STR.30.5.1118","article-title":"Apolipoprotein E deficiency worsens outcome from global ischemia in the mouse","volume":"30","author":"Sheng","year":"1999","journal-title":"Stroke"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J Clin Invest"},{"issue":"23","key":"10.1007\/s13311-023-01413-0_bib87","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1016\/S0021-9258(18)98578-9","article-title":"Only multimers of a synthetic peptide of human apolipoprotein e are biologically active","volume":"266","author":"Dyer","year":"1991","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-2275(20)39756-X","article-title":"Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor","volume":"36","author":"Dyer","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1007\/s13311-023-01413-0_bib89","doi-asserted-by":"crossref","first-page":"11142","DOI":"10.1021\/bi00035a020","article-title":"Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity","volume":"34","author":"Clay","year":"1995","journal-title":"Biochemistry"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.expneurol.2004.11.014","article-title":"A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury","volume":"192","author":"Lynch","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0404.2006.00680.x","article-title":"Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease","volume":"185","author":"Laskowitz","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"issue":"7","key":"10.1007\/s13311-023-01413-0_bib92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/neu.2008.0586","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"25","author":"Saatman","year":"2008","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib93","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4522(02)00709-1","article-title":"Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal-glial cultures","volume":"116","author":"Aono","year":"2003","journal-title":"Neuroscience"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib94","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2008.05.016","article-title":"N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein","volume":"55","author":"Sheng","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib95","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2003.08.017","article-title":"ApoE isoforms affect neuronal N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes","volume":"122","author":"Qiu","year":"2003","journal-title":"Neuroscience"},{"issue":"7","key":"10.1007\/s13311-023-01413-0_bib96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/neu.2006.0192","article-title":"COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury","volume":"24","author":"Laskowitz","year":"2007","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/neu.2008.0565","article-title":"COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain","volume":"26","author":"Hoane","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.expneurol.2012.11.027","article-title":"Apolipoprotein E mimetic peptides improve outcome after focal ischemia","volume":"241","author":"Wang","year":"2013","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib99","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12028-011-9641-5","article-title":"The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage","volume":"16","author":"Laskowitz","year":"2012","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1007\/s13311-023-01413-0_bib100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12975-016-0507-1","article-title":"Inhibition of blood-brain barrier disruption by an apolipoprotein e-mimetic peptide ameliorates early brain injury in experimental subarachnoid hemorrhage","volume":"8","author":"Pang","year":"2017","journal-title":"Transl Stroke Res"},{"issue":"9","key":"10.1007\/s13311-023-01413-0_bib101","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00221-022-06417-4","article-title":"Prophylactic treatment with CN-105 improves functional outcomes in a murine model of closed head injury","volume":"240","author":"Van Wyck","year":"2022","journal-title":"Exp Brain Res"},{"key":"10.1007\/s13311-023-01413-0_bib102","doi-asserted-by":"crossref","first-page":"46461","DOI":"10.1038\/srep46461","article-title":"Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcome in a traumatic brain injury murine model","volume":"7","author":"Laskowitz","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib103","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/svn-2018-000152","article-title":"The apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH","volume":"3","author":"Liu","year":"2018","journal-title":"Stroke and Vasc Neurol"},{"key":"10.1007\/s13311-023-01413-0_bib104","doi-asserted-by":"crossref","first-page":"39580","DOI":"10.1038\/srep39580","article-title":"Erratum: neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage","volume":"7","author":"Lei","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/acn3.399","article-title":"Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke","volume":"9","author":"Tu","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.677","article-title":"Antagonism of nicotinic acetylcholinergic receptors by CN-105, an apoE-mimetic peptide reduces stroke-induced excitotoxicity","volume":"12","author":"Xue","year":"2022","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1007\/s13311-023-01413-0_bib107","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jcph.853","article-title":"Phase I randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of a single escalating dose and repeated doses of CN-105 in healthy adult subjects","volume":"57","author":"Guptill","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib108","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.clinthera.2022.03.006","article-title":"Tolerability and pharmacokinetics of single escalating and repeated doses of CN-105 in healthy participants","volume":"44","author":"Li","year":"2022","journal-title":"Clin Ther"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12028-021-01287-0","article-title":"CN-105 in participants with acute supratentorial intracerebral hemorrhage (CATCH) trial","volume":"36","author":"James","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01413-0_bib110","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/STROKEAHA.113.002332","article-title":"The ethnic\/racial variations of intracerebral hemorrhage (erich) study protocol","volume":"44","author":"Woo","year":"2013","journal-title":"Stroke"},{"key":"10.1007\/s13311-023-01413-0_bib111","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT05826912, evaluation of CN-105 in subject with acute supratentorial intracerebral hemorrhage (S-CATCH). 2018 Oct 19 [cited 2023 Jul 03]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03711903."},{"key":"10.1007\/s13311-023-01413-0_bib112","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.anclin.2015.05.008","article-title":"Postoperative cognitive dysfunction: minding the gaps in our knowledge of a common postoperative complication in the elderly","volume":"33","author":"Berger","year":"2015","journal-title":"Anesthesiol Clin"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib113","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12974-016-0681-9","article-title":"Perioperative cerebrospinal fluid and plasma inflammatory markers after orthopedic surgery","volume":"13","author":"Hirsch","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib114","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3233\/JAD-191185","article-title":"The MARBLE study protocol: modulating apoE signaling to reduce brain inflammation, delirium, and postoperative cognitive dysfunction","volume":"75","author":"Van Dusen","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1007\/s13311-023-01413-0_bib115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1089\/neu.2006.0254","article-title":"The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury","volume":"24","author":"Hoane","year":"2007","journal-title":"J Neurotrauma"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib116","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.neuroscience.2006.11.017","article-title":"An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction","volume":"144","author":"Wang","year":"2007","journal-title":"Neuroscience"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib117","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/neu.2015.3887","article-title":"Apolipoprotein E-mimetic COG1410 reduces acute vasogenic edema following traumatic brain injury","volume":"33","author":"Cao","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01413-0_bib118","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1089\/neu.2012.2362","article-title":"Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice","volume":"13","author":"Jiang","year":"2012","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1007\/s13311-023-01413-0_bib119","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbr.2010.06.017","article-title":"COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat","volume":"214","author":"Kaufman","year":"2010","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1007\/s13311-023-01413-0_bib120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/neu.2016.4485","article-title":"Apolipoprotein E mimetic peptide increases cerebral glucose uptake by reducing blood-brain barrier disruption after controlled cortical impact in mice: an (18) F-fluorodeoxyglucose PET\/CT study","volume":"34","author":"Qin","year":"2017","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1007\/s13311-023-01413-0_bib121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40364-021-00325-5","article-title":"Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues","volume":"9","author":"Hier","year":"2021","journal-title":"Biomark Res"},{"key":"10.1007\/s13311-023-01413-0_bib122","series-title":"Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects","article-title":"CNS trauma biomarkers and surrogate endpoints pipeline from bench to bedside: a translational perspective.","author":"Mouhieddine","year":"2015"},{"issue":"9","key":"10.1007\/s13311-023-01413-0_bib123","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","article-title":"Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study","volume":"21","author":"Korley","year":"2022","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1007\/s13311-023-01413-0_bib124","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1007\/s13311-023-01413-0_bib125","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/acem.14366","article-title":"Accuracy of rapid glial fibrillary acidic protein\/ubiquitin carboxy-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury","volume":"28","author":"Bazarian","year":"2021","journal-title":"Acad Emerg Med"},{"key":"#cr-split#-10.1007\/s13311-023-01413-0_bib126.1","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT05826912, Multi-arm multi-stage adaptive platform trial (APT) for the acute treatment of traumatic brain injury (APT-TBI-01)"},{"key":"#cr-split#-10.1007\/s13311-023-01413-0_bib126.2","unstructured":"2023 Apr 24 [cited 2023 Jul 03]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05826912."},{"key":"10.1007\/s13311-023-01413-0_bib127","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-023-01399-9","article-title":"HMG-CoA reductase inhibitors for traumatic brain injury","author":"Katlowitz","year":"2023","journal-title":"Neurotherapeutics"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01413-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01413-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01413-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:18:54Z","timestamp":1761808734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923019931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1878747923019931"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01413-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01413-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}